• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性去除1型人嗜T细胞病毒p12I可降低体内病毒感染性。

Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.

作者信息

Collins N D, Newbound G C, Albrecht B, Beard J L, Ratner L, Lairmore M D

机构信息

Center for Retrovirus Research and the Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210-1093, USA.

出版信息

Blood. 1998 Jun 15;91(12):4701-7.

PMID:9616168
Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia and HTLV-1-associated myelopathy. Novel, yet conserved RNA transcripts encoded from open reading frames (ORFs) I and II of the viral pX region are expressed both in vitro and in infected individuals. The ORF I mRNA encodes the protein p12(I), which has been shown to localize to cellular endomembranes, cooperate with bovine papillomavirus E5 in transformation, as well as bind to the IL-2 receptor beta and gamma chains and the H+ vacuolar ATPase. It is unknown what role p12(I) plays in the viral life cycle. Using an infectious molecular clone of HTLV-1 (ACH) and a derivative clone, ACH.p12(I), which fails to produce the p12(I) message, we investigated the importance of p12(I) in infected primary cells and in a rabbit model of the infection. ACH.p12(I) was infectious in vitro as shown by viral passage in culture and no qualitative or quantitative differences were noted between ACH and ACH.p12(I) in posttransfection viral antigen production. However, in contrast to ACH, ACH.p12(I) failed to establish persistent infection in vivo as indicated by reduced anti-HTLV-1 antibody responses, failure to demonstrate viral p19 antigen production in peripheral blood mononuclear cell (PBMC) cultures, and only transient detection of provirus by polymerase chain reaction in PBMC from ACH.p12(I)-inoculated rabbits. These results are the first to show the essential role of HTLV-1 p12(I) in the establishment of persistent viral infection in vivo and suggest potential new targets in antiviral strategies to prevent HTLV-1 infection.

摘要

人类嗜T淋巴细胞病毒1型(HTLV-1)是成人T细胞白血病和HTLV-1相关脊髓病的病原体。病毒pX区域开放阅读框(ORF)I和II编码的新型且保守的RNA转录本在体外和受感染个体中均有表达。ORF I mRNA编码蛋白p12(I),该蛋白已被证明定位于细胞内膜,在转化过程中与牛乳头瘤病毒E5协同作用,还能与白细胞介素-2受体β链和γ链以及H⁺空泡型ATP酶结合。目前尚不清楚p12(I)在病毒生命周期中发挥何种作用。我们使用HTLV-1的感染性分子克隆(ACH)和一个不能产生p12(I)信使RNA的衍生克隆ACH.p12(I),研究了p12(I)在受感染原代细胞和兔感染模型中的重要性。ACH.p12(I)在体外具有感染性,如在培养物中的病毒传代所示,并且在转染后病毒抗原产生方面,ACH和ACH.p12(I)之间未观察到定性或定量差异。然而,与ACH不同,ACH.p12(I)在体内未能建立持续感染,这表现为抗HTLV-1抗体反应降低、在外周血单核细胞(PBMC)培养物中未能检测到病毒p19抗原产生,以及在接种ACH.p12(I)的兔的PBMC中通过聚合酶链反应仅短暂检测到前病毒。这些结果首次表明HTLV-1 p12(I)在体内建立持续病毒感染中的重要作用,并提示了预防HTLV-1感染的抗病毒策略中的潜在新靶点。

相似文献

1
Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.选择性去除1型人嗜T细胞病毒p12I可降低体内病毒感染性。
Blood. 1998 Jun 15;91(12):4701-7.
2
In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and II.1型人嗜T细胞病毒pX开放阅读框I和II的体外及体内功能分析
AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1757-64. doi: 10.1089/08892220050193272.
3
Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.人类嗜T淋巴细胞病毒1型开放阅读框I p12(I)是原代淋巴细胞中病毒高效感染所必需的。
J Virol. 2000 Nov;74(21):9828-35. doi: 10.1128/jvi.74.21.9828-9835.2000.
4
Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.人类嗜T淋巴细胞病毒1型pX开放阅读框II在体内维持病毒载量中的功能作用。
J Virol. 2000 Feb;74(3):1094-100. doi: 10.1128/jvi.74.3.1094-1100.2000.
5
Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion.1型人类嗜T细胞病毒开放阅读框II编码的p30II是体内复制所必需的:体内回复的证据。
J Virol. 2004 Apr;78(8):3837-45. doi: 10.1128/jvi.78.8.3837-3845.2004.
6
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.1型人类嗜T淋巴细胞病毒线粒体定位蛋白p13(II)是病毒体内感染性所必需的。
J Virol. 2006 Apr;80(7):3469-76. doi: 10.1128/JVI.80.7.3469-3476.2006.
7
Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.1型人类嗜T淋巴细胞病毒辅助蛋白在病毒复制和发病机制中的关键作用。
Microbiol Mol Biol Rev. 2002 Sep;66(3):396-406, table of contents. doi: 10.1128/MMBR.66.3.396-406.2002.
8
Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation.人类嗜T细胞病毒1型p12I在T细胞活化过程中增强白细胞介素-2的产生。
J Virol. 2003 Oct;77(20):11027-39. doi: 10.1128/jvi.77.20.11027-11039.2003.
9
Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo.人类嗜T淋巴细胞病毒I型(HTLV-I)的p12I蛋白对于HTLV-I在体内的传播及感染维持并非必需。
AIDS Res Hum Retroviruses. 2004 Oct;20(10):1092-9. doi: 10.1089/aid.2004.20.1092.
10
Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.人类嗜T淋巴细胞病毒1型(HTLV-1)辅助蛋白在病毒复制、T细胞活化及细胞基因表达中的作用
Front Biosci. 2004 Sep 1;9:2556-76. doi: 10.2741/1417.

引用本文的文献

1
Characterization of HTLV-1 Infectious Molecular Clone Isolated from Patient with HAM/TSP and Immortalization of Human Primary T-Cell Lines.从HAM/TSP患者分离的HTLV-1感染性分子克隆的鉴定及人原代T细胞系的永生化
Viruses. 2024 Nov 9;16(11):1755. doi: 10.3390/v16111755.
2
Intercellular Transport of Viral Proteins.病毒蛋白的细胞间转运。
Results Probl Cell Differ. 2024;73:435-474. doi: 10.1007/978-3-031-62036-2_18.
3
An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits.一种人嗜T淋巴细胞病毒1型包膜mRNA疫苗在新西兰兔中具有免疫原性且有保护作用。
J Virol. 2024 Feb 20;98(2):e0162323. doi: 10.1128/jvi.01623-23. Epub 2024 Jan 9.
4
Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion.人类嗜T淋巴细胞病毒1型(HTLV-1)固有免疫识别机制及病毒免疫逃逸
Pathogens. 2023 May 19;12(5):735. doi: 10.3390/pathogens12050735.
5
Hijacking Host Immunity by the Human T-Cell Leukemia Virus Type-1: Implications for Therapeutic and Preventive Vaccines.人 T 细胞白血病病毒 1 劫持宿主免疫:对治疗性和预防性疫苗的影响。
Viruses. 2022 Sep 20;14(10):2084. doi: 10.3390/v14102084.
6
The Past, Present, and Future of a Human T-Cell Leukemia Virus Type 1 Vaccine.人类T细胞白血病病毒1型疫苗的过去、现在与未来
Front Microbiol. 2022 May 4;13:897346. doi: 10.3389/fmicb.2022.897346. eCollection 2022.
7
Regulation of HTLV-1 transformation.调控 HTLV-1 转化。
Biosci Rep. 2022 Mar 31;42(3). doi: 10.1042/BSR20211921.
8
HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models.人类嗜 T 淋巴细胞病毒 1 型感染与发病机制:细胞和动物模型的新见解。
Int J Mol Sci. 2021 Jul 27;22(15):8001. doi: 10.3390/ijms22158001.
9
Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).基于表位的人嗜 T 淋巴细胞病毒 1(HTLV-1)通用疫苗。
PLoS One. 2021 Apr 2;16(4):e0248001. doi: 10.1371/journal.pone.0248001. eCollection 2021.
10
Transfer of HTLV-1 p8 and Gag to target T-cells depends on VASP, a novel interaction partner of p8.HTLV-1 p8 和 Gag 向靶 T 细胞的转移依赖于 VASP,这是 p8 的一个新的相互作用伙伴。
PLoS Pathog. 2020 Sep 30;16(9):e1008879. doi: 10.1371/journal.ppat.1008879. eCollection 2020 Sep.